Fig. 1From: Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomesComparison of daily medications of MuSK MG patients between the hospitalization period and at last follow-up. Daily dose of pyridostigmine bromide (A), corticosteroids (B) between the hospitalization period and at last follow-upBack to article page